- UroToday Home
- Urologic Oncology
The Latest Bladder Cancer Research
Recent Abstracts
-
Transcriptome-wide association study identifies genes associated with bladder cancer risk.Bladder CancerJanuary 16, 2025
-
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial.Bladder CancerJanuary 16, 2025
-
Diagnostic Accuracy of VI-RADS for Determining Muscle Invasion - Expert CommentaryBladder CancerJanuary 15, 2025
-
New Drug Application Initiated with U.S. FDA for TAR-200, the First and Only Intravesical Drug Releasing System for Patients with BCG-Unresponsive High-Risk Non-Muscle-Invasive Bladder CancerBladder CancerJanuary 15, 2025
-
Point-Based Prediction Model for Bladder Cancer Risk in Diabetes: A Random Survival Forest-Guided Approach.Bladder CancerJanuary 15, 2025
-
Feasibility and Oncological Outcome of Patients Achieving Noninvasive Downstaging After Transurethral Resection of Bladder Tumor Plus Systemic Chemotherapy for Bladder Preservation Strategy in Muscle-Invasive Bladder Cancer.Bladder CancerJanuary 15, 2025
-
Immediate second resection versus restage transurethral resection of bladder tumor: A prospective randomized clinical trial (IMMERSE trial).Bladder CancerJanuary 15, 2025
-
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group results.Bladder CancerJanuary 14, 2025
-
Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma.Bladder CancerJanuary 14, 2025
-
Treatment of metastatic urothelial carcinoma in the United Kingdom, France, Germany, Italy, and Spain.Bladder CancerJanuary 13, 2025
Beyond the Abstracts
-
Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review - Beyond the AbstractBladder CancerJanuary 10, 2025
-
Sensitive Detection of Urothelial Cancer via High-volume Urine DNA Analysis - Beyond the AbstractBladder CancerJanuary 9, 2025
-
Long-Term Recurrence Risk, Metastatic Potential and Length of Cystoscopic Surveillance of Low-Grade Non-Muscle Invasive Bladder Cancer - Beyond the AbstractBladder CancerJanuary 7, 2025
-
Tumor Location at Trans-Urethral Resection Is Predictive of Ipsilateral Pelvic Lymph-Nodal Metastases in Patients Undergoing Radical Cystectomy for Bladder Cancer - Beyond the AbstractBladder CancerDecember 10, 2024
-
Metastasis Development in Non-Muscle-Invasive Bladder Cancer - Beyond the AbstractBladder CancerDecember 9, 2024
-
Muscle-Invasive Bladder Cancer in Non-Curative Patients: A Study on Survival and Palliative Care Needs - Beyond the AbstractBladder CancerNovember 27, 2024
-
Perioperative Complications and In-Hospital Mortality in Paraplegic Radical Cystectomy Patients - Beyond the AbstractBladder CancerNovember 21, 2024
-
Perioperative Platform for Muscle-Invasive Bladder Cancer Trials: Designs and Endpoints - Beyond the AbstractBladder CancerNovember 21, 2024
-
Bladder Sparing Options for Muscle-Invasive Bladder Cancer - Beyond the AbstractBladder CancerNovember 20, 2024
-
Modulation of the Tumor Microenvironment in Non-Muscle-Invasive Bladder Cancer by OncoTherad® (MRB-CFI-1) Nanoimmunotherapy: Effects on Tumor-Associated Macrophages, Tumor-Infiltrating Lymphocytes, and Monoamine Oxidases - Beyond the AbstractBladder CancerNovember 20, 2024